24389444Pilotto S, Bria E, Peretti U, Massari F, Garassino M, Pelosi G, Tortora GJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerAdenocarcinoma; Drug Resistance, Neoplasm; ErbB Receptors; Gene Dosage; Lung Neoplasms; Mutation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Quinazolines; Receptor Protein-Tyrosine KinasesAged; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Crizotinib; DNA, Neoplasm; Female; Gefitinib; Humans; In Situ Hybridization, Fluorescence; Prognosis; Protein Kinase Inhibitors; Salvage TherapyLung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy number. J Thorac Oncol. 2013 Dec; 8(12):e105-6.J Thorac Oncol2013-12-01T00:00:002013Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy number.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000230Disorders29111600.582251AdenocarcinomaD000368Living Beings1341183530.294764AgedD000970Chemicals & Drugs40723510.435461Antineoplastic AgentsD004273Chemicals & Drugs1122650.914206DNA, NeoplasmD009154Physiology70239520.442648MutationD008175Disorders32822600.404525Lung NeoplasmsD005260Physiology1992444050.191167FemaleD011505Chemicals & Drugs1183020.866551Protein-Tyrosine KinasesD011518Chemicals & Drugs2306450.750392Proto-Oncogene ProteinsD011725Chemicals & Drugs1533090.839039PyridinesD006801Living Beings2262862810.130052HumansD019008Physiology1805890.751116Drug Resistance, NeoplasmMedicine-Hematology and OncologyD016879Procedures972320.889666Salvage TherapyMarina ChiaraGarassinoMarina Chiara Garassino41.7886000000000087.598699999999994025Garassino, Marina ChiaraProfessorAuthorship 14571240.1222440.1222441authors10.2522has subject areaD020794Chemicals & Drugs761530.900016Receptor Protein-Tyrosine KinasesD017404Procedures1463480.913343In Situ Hybridization, FluorescenceD011379Procedures74536690.561447PrognosisD011720Chemicals & Drugs841530.896041PyrazolesD011799Chemicals & Drugs652200.877229QuinazolinesD019859Chemicals & Drugs491990.86Proto-Oncogene Proteins c-metD018628Concepts & Ideas1102070.920345Gene DosageD066246Chemicals & Drugs1494850.779528ErbB ReceptorsD047428Chemicals & Drugs2065890.714193Protein Kinase InhibitorsUniversity of Chicagotrue1ProfessorProfessor